Trial · NCT00321464
Adverse events1,180
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,180
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Zoledronic Acid 4 mg Q4W | 217 | 1,013 | |
| other | Anaemia | Blood and lymphatic system disorders | Denosumab 120 mg Q4W | 183 | 1,020 | |
| other | Leukopenia | Blood and lymphatic system disorders | Zoledronic Acid 4 mg Q4W | 72 | 1,013 | |
| other | Leukopenia | Blood and lymphatic system disorders | Denosumab 120 mg Q4W | 78 | 1,020 | |
| other | Neutropenia | Blood and lymphatic system disorders | Zoledronic Acid 4 mg Q4W | 118 | 1,013 | |
| other | Neutropenia | Blood and lymphatic system disorders | Denosumab 120 mg Q4W | 114 | 1,020 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Zoledronic Acid 4 mg Q4W | 53 | 1,013 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Denosumab 120 mg Q4W | 62 | 1,020 | |
| other | Abdominal pain | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 113 | 1,013 | |
| other | Abdominal pain | Gastrointestinal disorders | Denosumab 120 mg Q4W | 114 | 1,020 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 80 | 1,013 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Denosumab 120 mg Q4W | 68 | 1,020 | |
| other | Constipation | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 203 | 1,013 | |
| other | Constipation | Gastrointestinal disorders | Denosumab 120 mg Q4W | 175 | 1,020 | |
| other | Diarrhoea | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 198 | 1,013 | |
| other | Diarrhoea | Gastrointestinal disorders | Denosumab 120 mg Q4W | 223 | 1,020 | |
| other | Dyspepsia | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 73 | 1,013 | |
| other | Dyspepsia | Gastrointestinal disorders | Denosumab 120 mg Q4W | 52 | 1,020 | |
| other | Nausea | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 377 | 1,013 | |
| other | Nausea | Gastrointestinal disorders | Denosumab 120 mg Q4W | 350 | 1,020 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00321464/events